Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Zellweger Spectrum Disorder
71%
Gastric Surgery
71%
Epigallocatechin-3-gallate
47%
Caregivers
47%
ApcMin Mouse
47%
Intake Methods
47%
Dietary Intake
47%
Weight Loss
30%
Intestinal Tumorigenesis
28%
Catechin
23%
Type 2 Diabetic Patients
23%
Green Tea
23%
Peptide YY3-36
23%
Caloric Restriction
23%
Tumorigenesis
23%
Rare Diseases
23%
5-Lipoxygenase (5-LOX)
23%
Disease Biomarkers
23%
Azoxymethane/dextran Sodium Sulfate
23%
Zellweger Spectrum
23%
Life-limiting
23%
Dipeptidyl peptidase-4 (DPP-4)
23%
Quality of Life Survey
23%
Fish Oil
23%
Obese Patients
23%
Gastric Bypass
20%
Dietary Assessment
20%
Nutrient Intake
20%
Beta-catenin
15%
Incretin
13%
Peroxisomal Disorders
13%
Family Caregivers
13%
3-day Food Records
13%
Complex Spectrum
11%
Shortened Lifespan
11%
Small Intestine Tissue
11%
Extracellular Concentrations
11%
Genetic Disease
10%
Intestinal Tumor
10%
Upper Body Obesity
9%
Nutritional Effects
9%
Equivalent Weight
8%
Adenoma
7%
Treatment Group
7%
Enhanced Engagement
7%
Apoptosis
7%
Circulating Amino Acids
6%
Peroxisome Biogenesis
6%
24-hour Dietary Recall
6%
Energy Intake
6%
Medicine and Dentistry
Spectrum Disorder
95%
Gastric Bypass Surgery
71%
Glucose
52%
Dietary Intake
47%
Peroxisomal Disorder
37%
Oral
30%
Incretin
27%
Peptide YY [3-36]
27%
Diseases
26%
Patient with Type 2 Diabetes
23%
Carcinogenesis
23%
Quality of Life
23%
Rare Disease
23%
Oxyntomodulin
23%
Dextran Sulfate
23%
Azoxymethane
23%
Rhizomelic Chondrodysplasia Punctata
23%
Scoping Review
23%
Nutrient Intake
20%
Nutrition Assessment
20%
High Fat Food
19%
Genetic Disorder
18%
Insulin
16%
Diabetes
15%
Maturity Onset Diabetes of the Young
13%
Glucagon Like Peptide 1
11%
Somatomedin C
9%
Beta-Catenin
9%
Intestine Tumor
9%
Peroxisome
9%
Biogenesis
9%
Body Weight
8%
Gastric Bypass
7%
Insulin Release
7%
Gastric Inhibitory Polypeptide
7%
Proinsulin
7%
Amylin
7%
Ghrelin
7%
Organ Systems
6%
Gastrointestinal Bleeding
6%
Clinical Intervention
6%
Energy Intake
6%
Diabetic Obesity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenesis
100%
Epigallocatechin Gallate
83%
Catechin
49%
Arachidonic Acid
32%
Intestine Cancer
26%
Polyphenon E
23%
Fish Oil
23%
Polyphenol
23%
Bioavailability
23%
Genistein
23%
Arachidonate 5 Lipoxygenase
23%
Prostaglandin Synthase
23%
Diketone
23%
Curcumin
23%
Cytosolic Phospholipase A2
23%
Azoxymethane
23%
Dextran Sulfate
23%
Intestine Tumor
19%
Catenin
15%
Prostaglandin E2
14%
Cyclooxygenase 2
13%
Colon Carcinoma
12%
Protein Kinase B
12%
Uvomorulin
10%
Lipopolysaccharide
10%
Adenoma
10%
Neoplasm
10%
Lipid
9%
Somatomedin C
9%
Beta Catenin
9%
Malignant Neoplasm
8%
Enzyme
7%
Treatment Group
7%
CF-1 Mouse
6%
Cyclooxygenase 1
5%